Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Semin Cancer Biol. 2019 Jul 2;57:27–35. doi: 10.1016/j.semcancer.2019.06.013

Fig. 4.

Fig. 4.

Prognostic value of mdig in human cancer. A. Higher expression of mdig predicts poorer overall survival of hepatocellular carcinoma; B. Higher expression of mdig predicts poorer progress free survival (PFS) of the stages I and II, but not the stages III and IV ovarian cancer. C. Association of higher mdig expression with poorer survival of the patients with pancreatic ductal adenocarcinoma (left) and renal papillary cell carcinoma (middle). Higher mdig level indicated better survival of the patients with rectum adenocarcinoma (right). The patient survival information is derived from Kaplan Meier-plotter (kmplot.com).